Nonclinical COVID-19 Vaccine Development During a Pandemic

The COVID-19 pandemic changed all of our lives in 2020.  Development of a COVID-19 vaccine required some re-thinking of the standard vaccine development paradigm.  The webinar will cover nonclinical development of the Pfizer-BioNTech CoVID-19 vaccine as well as some aspects specifically related to developing an mRNA vaccine and how that differed from a typical infectious disease nonclinical development program.

Learning Objectives: 

1. Provide brief overview of the typical approach to infectious disease vaccine development

2. Describe approach used for COVID-19 vaccine nonclinical development during a pandemic

3. Outline some points to consider in mRNA vaccine nonclinical development